Clinton Health Access Initiative

What it reported doing in 2024

Non-communicable diseases: non-communicable diseases (ncds) such as heart disease, cancer, chronic respiratory disease, and diabetes are the leading cause of death globally, exceeding all communicable disease deaths combined. In addition to our ncd program, which supports governments to strengthen and implement their ncd prevention and control strategies, chai is partnering with governments to strengthen cancer care systems by solving critical systemic gaps. We believe by working in close collaboration with partner governments and by anchoring a suite of transformational interventions, we can dramatically improve survival rates of cancer patients in low- and middle-income countries.cross-cutting experts: chai works with governments and companies around the world to fundamentally change the economics of global health. Using a holistic, business-minded approach to secure lower prices for key commodities such as medication and diagnostics, improve laboratories, and connect decision-makers with the high-quality evidence they need to inform health policy in low- and middle-income countries, chai helps patients access the care and treatment they need. Our science and business experts work across the organization to support our program and country teams. Chai works on both the supply and demand sides of the market to lower costs and increase availability of the best health products for low-and middle-income countries. Working with the public and private sectors, we help shape markets and realize savings for drugs, devices, and diagnostics in all areas of our work. Chai has negotiated over 140 global agreements to lower the prices of critical medications and other health tools by 50-90 percent. Twenty-seven million people living with HIV have been reached by one such agreement lowering the cost of the optimal HIV treatment tld, a savings of over $500 million. Through the global health sciences team, chai aims to reduce costs, improve quality, and increase access to treatment by helping to develop less expensive and more effective versions of critical medications for adults and children; developing techniques and technologies that advance our understanding and management of diseases; and improve patient care. This work has helped accelerate by over two years development, manufacture, regulatory approval, and commercialization of key pediatric HIV products, and saved billions in costs to governments for critical treatments.several new programs have also been added to chai's portfolio in recent years, significantly, assistive technology.

Financial Efficiency

• Mission deployment rate: 89.9%; rating input score 90
• Program expense ratio: 90.6%; rating input score 91
• Fundraising efficiency: $73.21 raised per $1 spent on fundraising; rating input score 80; 80th percentile among comparable filings

Transparency & Controls

• Consistency checks: 88.9%; rating input score 89; 3rd percentile among comparable filings
• Pay-setting controls: 5 of 6 controls in place; rating input score 83
  • Compensation committee: Pass
  • Independent consultant: Missing
  • Other Form 990s reviewed: Pass
  • Written employment contract: Pass
  • Compensation survey or study: Pass
  • Board or committee approval: Pass
• Foreign activity oversight: 1 of 8 controls in place; rating input score 12
  • Claims monitoring procedures: Pass
  • Requires narrative reports: Limited
  • Conducts field audits: Limited
  • May suspend future funding: Limited
  • Requires financial reports: Limited
  • Conducts site visits: Limited
  • Requires grant agreements: Limited
  • May require repayment: Limited
• Grant itemization coverage: 97.1%; rating input score 97; 31st percentile among comparable filings
• Major donor itemization: Yes; rating input score 100
• Related-party transparency: Limited

Accountability

• Independent voting board: 100%; rating input score 100; 77th percentile among comparable filings
• Governance controls: 9 of 9 controls in place; rating input score 100
  • Conflict-of-interest policy: Pass
  • Whistleblower policy: Pass
  • Document-retention policy: Pass
  • CEO compensation review process: Pass
  • Other executive compensation review process: Pass
  • Form 990 shared with the board: Pass
  • Board meeting minutes documented: Pass
  • Audit committee oversight: Pass
  • Independent financial-statement audit: Pass

Sustainability

• Operating margin: 1%; rating input score 37; 37th percentile among comparable filings
• Total-asset coverage ratio: 0.73; rating input score 29; 29th percentile among comparable filings
• Liabilities to assets ratio: 0.92; rating input score 10; 10th percentile among comparable filings
• Officer compensation ratio: 2.1%; rating input score 54; 54th percentile among comparable filings

Growth

• Program expense growth: 6.6% per year; rating input score 100; 54th percentile among comparable filings
• Revenue growth: 8% per year; rating input score 100; 67th percentile among comparable filings
• Asset growth: 6% per year; rating input score 100; 44th percentile among comparable filings